Karen Bhatt

Karen Bhatt is a leading clinical researcher in cancer-associated thrombosis, contributing to landmark trials comparing direct oral anticoagulants with low-molecular-weight heparin for VTE treatment in cancer patients and establishing evidence-based guidelines for anticoagulation management in oncology. Her research has validated the Khorana score for thrombosis risk stratification and contributed to understanding optimal anticoagulation duration in cancer patients. She has advanced the clinical adoption of DOACs in cancer-associated VTE. Her work has transformed the standard of care for thrombosis in cancer patients.